To further confirm whether ARHGAP25 regulates glycolysis and PAAD cell proliferation via the AKT/mTOR pathway, we treated sh-ARHGAP25 BxPC-3 cells with PF-04691502, a dual inhibitor of PI3K and mTOR. This evidence concerns the gene AKT1 and pancreatic adenocarcinoma.